Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
DHA:JHRML's 5-Year Yield-on-Cost % is ranked worse than 76.49% of 319
companies
in the Medical Devices & Instruments industry
Industry Median: 2.44
vs DHA:JHRML: 1.00
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
JMI Hospital Requisite Manufacturing 5-Year Yield-on-Cost % Related Terms
DHA:JHRML vs ISRG, BDX, MDLN: 5-Year Yield-on-Cost % Comparison
For the Medical Instruments & Supplies subindustry, JMI Hospital Requisite Manufacturing's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
JMI Hospital Requisite Manufacturing 5-Year Yield-on-Cost % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, JMI Hospital Requisite Manufacturing's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where JMI Hospital Requisite Manufacturing's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
JMI Hospital Requisite Manufacturing (DHA:JHRML) has a 5-Year Yield-on-Cost % of 1.00 as of Aug. 02, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on JMI Hospital Requisite Manufacturing and its competitors. This is 36% below median its historical median of 1.56. Over the past decade, JMI Hospital Requisite Manufacturing's 5-Year Yield-on-Cost % has ranged from 0.66 to 2.40. According to the industry distribution chart, JMI Hospital Requisite Manufacturing ranks #244 out of 319 companies in the Medical Devices & Instruments industry, placing it in the top 76.5%.
Is JMI Hospital Requisite Manufacturing's 5-Year Yield-on-Cost % too high?
JMI Hospital Requisite Manufacturing's current 5-Year Yield-on-Cost % of 1.00 is 36% below median its 10-year median of 1.56. Over the past 10 years, this metric has ranged from a low of 0.66 to a high of 2.40. The Medical Devices & Instruments industry median 5-Year Yield-on-Cost % is 2.44. JMI Hospital Requisite Manufacturing's value of 1.00 is 59% below this industry median. Based on the distribution chart, JMI Hospital Requisite Manufacturing ranks #244 out of 319 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, JMI Hospital Requisite Manufacturing has a GF Score™ of 68/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does JMI Hospital Requisite Manufacturing's 5-Year Yield-on-Cost % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, JMI Hospital Requisite Manufacturing ranks #244 out of 319 companies for 5-Year Yield-on-Cost %. This places JMI Hospital Requisite Manufacturing in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.44. JMI Hospital Requisite Manufacturing's value of 1.00 is 59% below this benchmark. Historically, JMI Hospital Requisite Manufacturing's own 5-Year Yield-on-Cost % has ranged from 0.66 to 2.40 over the past decade. While the company's 10-year median is 1.56 vs. the industry median of 2.44, JMI Hospital Requisite Manufacturing has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Devices & Instruments company?
The median 5-Year Yield-on-Cost % among Medical Devices & Instruments companies is 2.44, based on 319 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. JMI Hospital Requisite Manufacturing's current 5-Year Yield-on-Cost % of 1.00 is 59% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on JMI Hospital Requisite Manufacturing and its competitors. For the Medical Devices & Instruments industry, the median 5-Year Yield-on-Cost % is 2.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. JMI Hospital Requisite Manufacturing's current 5-Year Yield-on-Cost % is 1.00, which is 36% below median its own 10-year median of 1.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JMI Hospital Requisite Manufacturing stock overvalued right now?
Based on GuruFocus' analysis, JMI Hospital Requisite Manufacturing (DHA:JHRML) is currently considered Fairly Valued. The stock's GF Value™ is BDT50.63, compared to a current price of BDT49.90 — trading 1.4% below its estimated fair value. The current 5-Year Yield-on-Cost % is 1.00, which is 36% below median its 10-year median of 1.56 and 59% below the Medical Devices & Instruments industry median of 2.44. JMI Hospital Requisite Manufacturing's overall GF Score™ is 68/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For JMI Hospital Requisite Manufacturing (DHA:JHRML), the current 5-Year Yield-on-Cost % is 1.00 as of Aug. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is JMI Hospital Requisite Manufacturing (DHA:JHRML) Overvalued in 2026?
Based on GuruFocus' analysis, JMI Hospital Requisite Manufacturing stock appears to be undervalued.
The current stock price of BDT49.90 is trading 1.4% below its estimated GF Value™ of BDT50.63.
GuruFocus considers JMI Hospital Requisite Manufacturing to be Fairly Valued.
Key valuation signals for DHA:JHRML:
5-Year Yield-on-Cost %: 1.00 (36% below median its 10-year median of 1.56)
GF Value™: BDT50.63 vs. price of BDT49.90 (1.4% below fair value)
Industry Position: 59% below the Medical Devices & Instruments median (#244 of 319)
No single metric tells the full story. See the DHA:JHRML stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
JMI Hospital Requisite Manufacturing Ltd is engaged in the production of medical devices and components. The company produces health & hospicare products. The products of the company include Surgical Sutures, Surgical Gloves, IV Cannula, Bulk Needles, Blister Film, Infusion Set Components, Disposable Scalpels, Nasal Oxygen Cannulas, Blood Transfusion Sets, Urine Drainage Bags, Scalp Vein Sets, and others.
68GF Score
Get the complete analysis for DHA:JHRML
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DHA:JHRML has been successfully added to your 
